Makucell

Date Funded: 2012
Amount Funded: not disclosed

Makucell is a new life science company that utilizes an innovative proprietary regenerative medicine technology to address aging skin, hair and nails in an entirely new way. Using a patent-pending new molecule, Asymmtate™, Makucell has developed non-prescription products that work with the skin’s own stem cells to produce healthier and more youthful appearing skin. Makucell is introducing the Renewnt™ (pronounced “Re-new-int”) brand of products based on its proprietary technology.

Makucell was founded in September 2010 by distinguished researcher Michael Kahn, Ph.D., and colleagues at the Eli & Edythe Broad Center for Stem Cell and Regenerative Medicine at the University of Southern California Keck School of Medicine. The Makucell founders and industry experienced management team have a passion for utilizing the company’s core technology to develop new applications directed toward the challenges of aging and photoaging.

Makucell